Pfizer Inc (PFE)

$27.28 +0.32 (1.19%)
Market Cap 153.30B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.29
Forward PE 9.01
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 37,603,800
Avg Vol 46,815,828
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 64%
Beta 0.47
Analysts Sell
Price Target $28.94

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich Mar. 26 at 2:31 PM
$PFE you don't want this to fly to 28 .this should stay in this range for today and back off to the low 27s .and stay range bound for a week or 2 .build a nice support. Then you move up .do it slow with structure....ot will go to 28 soon enough .don't rush this ..
0 · Reply
1hawk
1hawk Mar. 26 at 2:19 PM
$PFE id rather not see this go up. In the green but didnt want to average up but guess ill have too now
1 · Reply
traderheadnyc
traderheadnyc Mar. 26 at 2:17 PM
$PFE this war had turned attention to this company. If they get one good news on their trials we be over 30-35
0 · Reply
SkyHighTrading
SkyHighTrading Mar. 26 at 2:12 PM
$PFE over 28 today?
1 · Reply
JFDI
JFDI Mar. 26 at 2:05 PM
$PFE B/O
0 · Reply
BustaCapital
BustaCapital Mar. 26 at 2:05 PM
$PFE is about to make new yearly highs (don't like this company at all fwiw) but dividend is decent and flows into healtcare will continue here in Q2
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 26 at 1:59 PM
$PFE
1 · Reply
doubleuptwice
doubleuptwice Mar. 26 at 1:53 PM
$PFE just know if we break above that wall this accumulation period is over a year long . Longerer the accumulation bigger the move
0 · Reply
NomadiCapital
NomadiCapital Mar. 26 at 1:53 PM
$PFE showing massive strength compared to the market. When the market bottoms/bounces, PFE flys
0 · Reply
doubleuptwice
doubleuptwice Mar. 26 at 1:48 PM
$PFE 27.82 and we’re off 🚀
1 · Reply
Latest News on PFE
Pfizer: Undervalued High-Yield Giant With A Pipeline Built For The Next Decade

Mar 25, 2026, 9:15 AM EDT - 1 day ago

Pfizer: Undervalued High-Yield Giant With A Pipeline Built For The Next Decade

Pfizer: Time To Buy The Turnaround

Mar 25, 2026, 2:06 AM EDT - 1 day ago

Pfizer: Time To Buy The Turnaround

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 2 days ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 2 days ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 2 days ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 3 days ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 3 days ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 3 days ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 3 days ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 3 days ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 4 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 5 days ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 7 days ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 7 days ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer: I'm Still Expecting A Massive Rebound

Mar 18, 2026, 9:00 AM EDT - 8 days ago

Pfizer: I'm Still Expecting A Massive Rebound

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 9 days ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 9 days ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Mar 13, 2026, 5:01 PM EDT - 12 days ago

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 17 days ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 17 days ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

Mar 7, 2026, 8:15 AM EST - 19 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

ADP ARCC BX CAG GLPI MPLX MSFT

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

Mar 6, 2026, 6:05 AM EST - 20 days ago

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

AMD GOOG GOOGL LLY NVDA NVO

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 20 days ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 20 days ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 21 days ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR ARE BBY BEN BXP CAG CCI

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

Mar 4, 2026, 9:09 AM EST - 22 days ago

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 22 days ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer's Quiet Cash Comeback

Mar 3, 2026, 9:50 AM EST - 22 days ago

Pfizer's Quiet Cash Comeback

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 23 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 1:27 PM EST - 23 days ago

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 23 days ago

Pfizer CEO flags issues with FDA's vaccine leadership

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

Mar 2, 2026, 4:51 AM EST - 24 days ago

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

ABBV AMGN AVGO BTI DIV ENB GTY

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

Mar 1, 2026, 8:10 AM EST - 25 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

ARCC BBVA E EQNR ETD FINV GSL

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 26 days ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

Feb 26, 2026, 7:48 AM EST - 4 weeks ago

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

BBY CAG EQR FRT KEY KMI LYB

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 4 weeks ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 4 weeks ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 4 weeks ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 4 weeks ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 4 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 4 weeks ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 5 weeks ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 5 weeks ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 5 weeks ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 5 weeks ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 5 weeks ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 6 weeks ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 6 weeks ago

Pfizer: A Great Opportunity Post Earnings

2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 6 weeks ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 6 weeks ago

Is Pfizer Stock Now A Value Trap?

Willieberich
Willieberich Mar. 26 at 2:31 PM
$PFE you don't want this to fly to 28 .this should stay in this range for today and back off to the low 27s .and stay range bound for a week or 2 .build a nice support. Then you move up .do it slow with structure....ot will go to 28 soon enough .don't rush this ..
0 · Reply
1hawk
1hawk Mar. 26 at 2:19 PM
$PFE id rather not see this go up. In the green but didnt want to average up but guess ill have too now
1 · Reply
traderheadnyc
traderheadnyc Mar. 26 at 2:17 PM
$PFE this war had turned attention to this company. If they get one good news on their trials we be over 30-35
0 · Reply
SkyHighTrading
SkyHighTrading Mar. 26 at 2:12 PM
$PFE over 28 today?
1 · Reply
JFDI
JFDI Mar. 26 at 2:05 PM
$PFE B/O
0 · Reply
BustaCapital
BustaCapital Mar. 26 at 2:05 PM
$PFE is about to make new yearly highs (don't like this company at all fwiw) but dividend is decent and flows into healtcare will continue here in Q2
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 26 at 1:59 PM
$PFE
1 · Reply
doubleuptwice
doubleuptwice Mar. 26 at 1:53 PM
$PFE just know if we break above that wall this accumulation period is over a year long . Longerer the accumulation bigger the move
0 · Reply
NomadiCapital
NomadiCapital Mar. 26 at 1:53 PM
$PFE showing massive strength compared to the market. When the market bottoms/bounces, PFE flys
0 · Reply
doubleuptwice
doubleuptwice Mar. 26 at 1:48 PM
$PFE 27.82 and we’re off 🚀
1 · Reply
TheUnmaker
TheUnmaker Mar. 26 at 1:48 PM
$TNXP $PFE load the dip!
0 · Reply
LadsAndGents
LadsAndGents Mar. 26 at 1:44 PM
$PFE market down and we should go up .. show me 28+ by tomorrow
1 · Reply
ProTraderColin
ProTraderColin Mar. 26 at 1:32 PM
$PFE looks good. Been swinging commons for years waiting for 30+
0 · Reply
DragoniteT
DragoniteT Mar. 26 at 1:30 PM
$JNJ $PFE $UNH shut up bot
0 · Reply
ChartMill
ChartMill Mar. 26 at 1:26 PM
5 potential breakout setups on ChartMill’s radar 👀 $PFE $BG $DVA $WLY $GILT Tight price action. Resistance nearby. Possible breakout candidates. Which one breaks out first? #stocks #trading #breakout #technicalanalysis
0 · Reply
MorganHoratio
MorganHoratio Mar. 26 at 1:14 PM
BIG DAY FOR $NVO — LEADERSHIP UNDER THE MICROSCOPE All eyes on Novo as Chairman Lars Rebien Sørensen steps up at today’s annual meeting — his first appearance since the boardroom shake-up This isn’t routine… it’s a credibility test. Investors want answers on strategy, governance, and what comes NEXT. $NVO / $NOVO.X: Can leadership stabilize sentiment and keep the growth story intact? $PFE: Watching closely as big pharma rivalry + market positioning stay in focus
0 · Reply
Dy2ski
Dy2ski Mar. 26 at 12:22 PM
$ENTA With the infringement suit also proceeding in the EU this summer, it might be in $PFE best interest to settle.
0 · Reply
EthelBurkhardt272
EthelBurkhardt272 Mar. 26 at 12:00 PM
healthcare demand doesn’t wait for market cycles $JNJ $UNH $PFE
0 · Reply
samsha1
samsha1 Mar. 26 at 6:21 AM
$SLS $PFE Sellas key to Seagen like valuation is the WT-1 platform with 5 year dosing protocol, it will be unlocked soon halt at HR<.36 and final HR at <.2 with 5 year dosing regimen or lifetime/ ad infinitum especially in the elderly.
1 · Reply
Ramiz888817
Ramiz888817 Mar. 26 at 3:27 AM
$DVN $PFE ahh how just a few percentage points make a huge swing in shareholder sentiment. Few months ago the post on this board were so negative you would of thought that pfe is about file for bankruptcy. In 3-5 years i can easily see pfe trading intriple digits. With 7.5% ( on cost) divy and a few cc sold here and there i can easily get 10-12% annual return while waiting for the market to price this appropriately.
1 · Reply
DragonAlgo
DragonAlgo Mar. 26 at 1:41 AM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-03-27 | Strike: $27.00 | Type: CALL Option Plan (premium): Entry: $0.43 Stop: $0.31 TP1: $0.56 TP2: $0.73 TP3: $1.03 🔗 https://dragonalgo.com
0 · Reply
EmbraceVolatility
EmbraceVolatility Mar. 26 at 12:57 AM
$PFE Yup
1 · Reply